Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 27566591)

  • 1. Lunasin is a novel therapeutic agent for targeting melanoma cancer stem cells.
    Shidal C; Al-Rayyan N; Yaddanapudi K; Davis KR
    Oncotarget; 2016 Dec; 7(51):84128-84141. PubMed ID: 27566591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The soy-derived peptide Lunasin inhibits invasive potential of melanoma initiating cells.
    Shidal C; Inaba JI; Yaddanapudi K; Davis KR
    Oncotarget; 2017 Apr; 8(15):25525-25541. PubMed ID: 28424421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The soybean-derived peptide lunasin inhibits non-small cell lung cancer cell proliferation by suppressing phosphorylation of the retinoblastoma protein.
    McConnell EJ; Devapatla B; Yaddanapudi K; Davis KR
    Oncotarget; 2015 Mar; 6(7):4649-62. PubMed ID: 25609198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting cancer initiating cells by promoting cell differentiation and restoring chemosensitivity via dual inactivation of STAT3 and src activity using an active component of antrodia cinnamomea mycelia.
    Chang CW; Chen YS; Chen CC; Chan IO; Chen CC; Sheu SJ; Lin TW; Chou SH; Liu CJ; Lee TC; Lo JF
    Oncotarget; 2016 Nov; 7(45):73016-73031. PubMed ID: 27682875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo anti-uveal melanoma activity of JSL-1, a novel HDAC inhibitor.
    Wang Y; Liu M; Jin Y; Jiang S; Pan J
    Cancer Lett; 2017 Aug; 400():47-60. PubMed ID: 28455241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma.
    Petrachi T; Romagnani A; Albini A; Longo C; Argenziano G; Grisendi G; Dominici M; Ciarrocchi A; Dallaglio K
    Oncotarget; 2017 Jan; 8(4):6914-6928. PubMed ID: 28036292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan.
    Emmink BL; Van Houdt WJ; Vries RG; Hoogwater FJ; Govaert KM; Verheem A; Nijkamp MW; Steller EJ; Jimenez CR; Clevers H; Borel Rinkes IH; Kranenburg O
    Gastroenterology; 2011 Jul; 141(1):269-78. PubMed ID: 21459094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny.
    Cheli Y; Giuliano S; Botton T; Rocchi S; Hofman V; Hofman P; Bahadoran P; Bertolotto C; Ballotti R
    Oncogene; 2011 May; 30(20):2307-18. PubMed ID: 21278797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LY6/PLAUR domain containing 3 has a role in the maintenance of colorectal cancer stem-like cells.
    Wang L; Hirohashi Y; Ogawa T; Shen M; Takeda R; Murai A; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Nishidate T; Okita K; Kutomi G; Sato N; Takemasa I; Torigoe T
    Biochem Biophys Res Commun; 2017 Apr; 486(2):232-238. PubMed ID: 28238780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the cancer initiating cell: the ultimate target for cancer therapy.
    McCubrey JA; Steelman LS; Abrams SL; Misaghian N; Chappell WH; Basecke J; Nicoletti F; Libra M; Ligresti G; Stivala F; Maksimovic-Ivanic D; Mijatovic S; Montalto G; Cervello M; Laidler P; Bonati A; Evangelisti C; Cocco L; Martelli AM
    Curr Pharm Des; 2012; 18(13):1784-95. PubMed ID: 22394167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells.
    Cheng W; Liu T; Wan X; Gao Y; Wang H
    FEBS J; 2012 Jun; 279(11):2047-59. PubMed ID: 22498306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hedgehog-GLI signaling drives self-renewal and tumorigenicity of human melanoma-initiating cells.
    Santini R; Vinci MC; Pandolfi S; Penachioni JY; Montagnani V; Olivito B; Gattai R; Pimpinelli N; Gerlini G; Borgognoni L; Stecca B
    Stem Cells; 2012 Sep; 30(9):1808-18. PubMed ID: 22730244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory Factors Control the Fate of Melanoma Tumor Initiating Cells.
    Tuccitto A; Tazzari M; Beretta V; Rini F; Miranda C; Greco A; Santinami M; Patuzzo R; Vergani B; Villa A; Manenti G; Cleris L; Giardiello D; Alison M; Rivoltini L; Castelli C; Perego M
    Stem Cells; 2016 Oct; 34(10):2449-2460. PubMed ID: 27301067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.
    Wang L; Park P; La Marca F; Than KD; Lin CY
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):1013-24. PubMed ID: 25431339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-initiating cells derived from human rectal adenocarcinoma tissues carry mesenchymal phenotypes and resist drug therapies.
    Fan CW; Chen T; Shang YN; Gu YZ; Zhang SL; Lu R; OuYang SR; Zhou X; Li Y; Meng WT; Hu JK; Lu Y; Sun XF; Bu H; Zhou ZG; Mo XM
    Cell Death Dis; 2013 Oct; 4(10):e828. PubMed ID: 24091671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dioxin receptor regulates aldehyde dehydrogenase to block melanoma tumorigenesis and metastasis.
    Contador-Troca M; Alvarez-Barrientos A; Merino JM; Morales-Hernández A; Rodríguez MI; Rey-Barroso J; Barrasa E; Cerezo-Guisado MI; Catalina-Fernández I; Sáenz-Santamaría J; Oliver FJ; Fernandez-Salguero PM
    Mol Cancer; 2015 Aug; 14():148. PubMed ID: 26242870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin targets gastric cancer stem cells.
    Courtois S; Durán RV; Giraud J; Sifré E; Izotte J; Mégraud F; Lehours P; Varon C; Bessède E
    Eur J Cancer; 2017 Oct; 84():193-201. PubMed ID: 28822889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cuprous oxide nanoparticle-inhibited melanoma progress by targeting melanoma stem cells.
    Yu B; Wang Y; Yu X; Zhang H; Zhu J; Wang C; Chen F; Liu C; Wang J; Zhu H
    Int J Nanomedicine; 2017; 12():2553-2567. PubMed ID: 28435246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenografts.
    Orecchia P; Conte R; Balza E; Pietra G; Mingari MC; Carnemolla B
    Oncotarget; 2015 Nov; 6(35):37426-42. PubMed ID: 26460958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoted delivery of salinomycin sodium to lung cancer cells by dual targeting PLGA hybrid nanoparticles.
    Zhou J; Sun J; Chen H; Peng Q
    Int J Oncol; 2018 Sep; 53(3):1289-1300. PubMed ID: 30015824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.